Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > VA Providers

Dr. David Z. Chang, MD, PHD, FACP

Accepting New Patients

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

Dartmouth Medical School

Professional interests include: cancer

3000 Coliseum Drive Suite 104
Hampton, VA 23666

(757) 873-9800

Dr. David Z. Chang, MD, PHD, FACP is a medical oncologist in Newport News, VA specializing in medical oncology, adult oncology and adult hematology. He graduated from Dartmouth Medical School. Dr. David Z. Chang, MD, PHD, FACP is affiliated with Bon Secours Mary Immaculate Hospital, Bon Secours, Bon Secours Mary Immaculate Hospital, Virginia Oncology Associates and Sentara Health.

Office Locations

Virginia Oncology Associates

1051 Loftis Boulevard Suite 100
Newport News, VA 23606

(757) 873-9400

open_in_new

Sentara Health

3000 Coliseum Drive Suite 104
Hampton, VA 23666

(757) 873-9800

open_in_new

In The News (see more mentions in the news)

“Dr. David Chang at Virginia Oncology Associates, which has received donations and welcomes more, expressed gratitude for donors who have given up their own personal protective equipment knowing...”—"The Helpers: Chinese-American families rally to find medical supplies for Hampton Roads hospitals", The Virginian-Pilot, April 2020

“He is also survived by his niece Heather, and nephews Paul Jr. and Greg.Stan's family would like to thank Dr. David Chang, Nurse Rachel, and the staff at Virginia Oncology Associates, as well as,...”—"Stanton Leman DeHaven", Daily Press, December 2018

“The family wants to give a special thank you to Dr. David Chang, nurse Leslie, the entire staff at Virginia Oncology, and Heartland Hospice for their loving care of Rebecca.”—"Rebecca Lynne Southcombe", Daily Press, October 2015

Noteworthy Medicare Patient Procedures Performed by Dr. David Z. Chang, MD, PHD, FACP in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

port flush

By Affordability:

CA 19-9 test

immunofixation electrophoresis

protein electrophoresis

serum protein electrophoresis

In 2023, among providers in related specialties within Virginia, Dr. David Z. Chang, MD, PHD, FACP performed more port flush procedures for Medicare patients than 95% of them and he also had a list price for CA 19-9 test, immunofixation electrophoresis (IFE), protein electrophoresis, and serum protein electrophoresis (SPEP) that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Volume:

urinalysis

By Affordability:

folic acid tests

sed rate

serum folate test

In 2023, among providers in related specialties within Virginia, Dr. David Z. Chang, MD, PHD, FACP performed more urinalysis procedures for Medicare patients than 90% of them and he also had a list price for folic acid tests, sed rate (ESR), and serum folate test that was lower than the list prices billed to Medicare by 90% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

inpatient hospital care

lactate dehydrogenase test

thyroid blood test

By Affordability:

blood count tests

blood draw

blood draw for lab tests

cancer antigen tests

carcinoembryonic antigen test

lactate dehydrogenase test

phlebotomy for lab tests

prostate-specific antigen test

quantitative Ig tests

reticulocyte count

thyroid function tests

In 2012, among providers in related specialties within Virginia, Dr. David Z. Chang, MD, PHD, FACP performed more inpatient hospital care (for patient admitted to hospital), lactate dehydrogenase (LDH) test, and thyroid blood test procedures for Medicare patients than 75% of them and he also had a list price for blood count tests, blood draw, blood draw for lab tests, cancer antigen tests, carcinoembryonic antigen (CEA) test, complete blood count (CBC), IgA test, IgD test, IgG test, IgM test, immunoglobulin tests, iron tests, lactate dehydrogenase (LDH) test, phlebotomy for lab tests, prostate-specific antigen (PSA) test, quantitative Ig tests, reticulocyte count (immature red blood cell count), thyroid function tests, total IgA test, total IgG test, total PSA test, uric acid blood test, uric acid test, urinalysis, venipuncture (phlebotomy), and vitamin B12 test that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2012 were lab tests, hospital care, inpatient care and minimally invasive procedures.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	389
blood draw	325
chemotherapy	389
doctor visit	1258
hormone therapy	16
hospital care	452
inpatient care	452
lab tests	3168
minimally invasive procedures	451
preventive care	19
vaccines	19

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2013 were lab tests, hospital care, inpatient care and minimally invasive procedures.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	440
blood draw	293
chemotherapy	440
doctor visit	1391
hormone therapy	24
hospital care	558
inpatient care	558
lab tests	3386
minimally invasive procedures	542
preventive care	29
thyroid function tests	22
vaccines	29

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	329
Female	414

**Ethnicity**
Non-Hispanic White	448
Black	268
Hispanic	0
Asian	13
Other	0
Native American	0

**Age**
From 65 to 74	316
From 75 to 84	262
85 and over	65
Less than 65	100

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2013

Hypertension	73
High Cholesterol	52
Stroke	5
Ischemic Heart Disease	36
Depression	20
Chronic Kidney Disease	35
Asthma	10
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	20
Chronic Obstructive Pulmonary Disease	19
Diabetes	38
Dementia	10
Cancer	49

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2014 were lab tests, minimally invasive procedures, hospital care and inpatient care.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	401
blood draw	324
chemotherapy	401
doctor visit	1207
hormone therapy	17
hospital care	424
inpatient care	424
lab tests	3199
minimally invasive procedures	617
port flush	14
preventive care	45
thyroid function tests	18
vaccines	45

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	295
Female	371

**Ethnicity**
Non-Hispanic White	403
Black	237
Hispanic	0
Asian	12
Other	0
Native American	0

**Age**
From 65 to 74	278
From 75 to 84	226
85 and over	61
Less than 65	101

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2014

Hypertension	70
High Cholesterol	55
Stroke	4
Ischemic Heart Disease	37
Depression	18
Chronic Kidney Disease	33
Asthma	9
Osteoperosis	9
Atrial Fibrilation	14
Heart Failure	18
Chronic Obstructive Pulmonary Disease	19
Diabetes	34
Dementia	8
Cancer	49

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2015 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	504
blood draw	365
chemotherapy	504
doctor visit	1254
hormone therapy	18
hospital care	308
inpatient care	308
lab tests	3082
minimally invasive procedures	667
port flush	33
preventive care	45
thyroid function tests	29
vaccines	45

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	568
Female	652

**Ethnicity**
Non-Hispanic White	756
Black	420
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	512
From 75 to 84	450
85 and over	116
Less than 65	142

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2015

Hypertension	71
High Cholesterol	56
Stroke	5
Ischemic Heart Disease	41
Depression	19
Chronic Kidney Disease	40
Asthma	15
Osteoperosis	9
Atrial Fibrilation	12
Heart Failure	21
Chronic Obstructive Pulmonary Disease	19
Diabetes	37
Dementia	10
Cancer	48

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2016 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

aspiration	11
biological response modifier (BRM) therapy	626
blood draw	446
bone marrow tests	22
chemotherapy	626
diagnostic procedures	22
doctor visit	1416
hormone therapy	32
hospital care	292
inpatient care	292
lab tests	3990
minimally invasive procedures	776
port flush	35
preventive care	42
thyroid function tests	57
vaccines	29

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	293
Female	370

**Ethnicity**
Non-Hispanic White	415
Black	218
Hispanic	0
Asian	14
Other	0
Native American	0

**Age**
From 65 to 74	294
From 75 to 84	238
85 and over	60
Less than 65	71

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2016

Hypertension	75
High Cholesterol	58
Stroke	4
Ischemic Heart Disease	41
Depression	20
Chronic Kidney Disease	40
Asthma	24
Osteoperosis	10
Atrial Fibrilation	12
Heart Failure	20
Chronic Obstructive Pulmonary Disease	20
Diabetes	38
Dementia	11
Cancer	47

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2017 were lab tests, minimally invasive procedures, blood draw and chemotherapy.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	443
blood draw	503
chemotherapy	443
doctor visit	1409
hormone therapy	17
hospital care	389
inpatient care	389
lab tests	4834
minimally invasive procedures	609
port flush	63
preventive care	29
thyroid function tests	73
vaccines	29

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	341
Female	440

**Ethnicity**
Non-Hispanic White	499
Black	238
Hispanic	0
Asian	23
Other	0
Native American	0

**Age**
From 65 to 74	357
From 75 to 84	275
85 and over	76
Less than 65	73

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2017

Hypertension	72
High Cholesterol	45
Stroke	4
Ischemic Heart Disease	42
Depression	18
Chronic Kidney Disease	41
Asthma	9
Osteoperosis	10
Atrial Fibrilation	11
Heart Failure	22
Chronic Obstructive Pulmonary Disease	21
Diabetes	37
Dementia	11
Cancer	46

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2018 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	718
blood draw	612
chemotherapy	718
doctor visit	1725
hormone therapy	29
hospital care	310
inpatient care	310
lab tests	5524
minimally invasive procedures	865
port flush	91
preventive care	31
thyroid function tests	85
vaccines	31

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	418
Female	555

**Ethnicity**
Non-Hispanic White	626
Black	299
Hispanic	0
Asian	22
Other	0
Native American	0

**Age**
From 65 to 74	426
From 75 to 84	341
85 and over	107
Less than 65	99

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2018

Hypertension	75
High Cholesterol	59
Stroke	5
Ischemic Heart Disease	39
Depression	21
Chronic Kidney Disease	44
Asthma	9
Osteoperosis	12
Atrial Fibrilation	13
Heart Failure	22
Chronic Obstructive Pulmonary Disease	21
Diabetes	39
Dementia	12
Cancer	45

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2019 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	702
blood draw	681
chemotherapy	702
doctor visit	1730
hormone therapy	23
hospital care	317
inpatient care	317
lab tests	5990
minimally invasive procedures	911
port flush	89
thyroid function tests	167

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	435
Female	532

**Ethnicity**
Non-Hispanic White	645
Black	274
Hispanic	0
Asian	23
Other	0
Native American	0

**Age**
From 65 to 74	427
From 75 to 84	337
85 and over	104
Less than 65	99

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2019

Hypertension	73
High Cholesterol	58
Stroke	6
Ischemic Heart Disease	40
Depression	23
Chronic Kidney Disease	43
Asthma	8
Osteoperosis	12
Atrial Fibrilation	13
Heart Failure	25
Chronic Obstructive Pulmonary Disease	23
Diabetes	37
Dementia	11
Cancer	44

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2020 were lab tests, minimally invasive procedures, blood draw and chemotherapy.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	511
blood draw	607
chemotherapy	511
doctor visit	1272
hormone therapy	46
hospital care	172
inpatient care	172
lab tests	5766
minimally invasive procedures	712
port flush	91
preventive care	20
thyroid function tests	146

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	352
Female	509

**Ethnicity**
Non-Hispanic White	596
Black	219
Hispanic	0
Asian	15
Other	16
Native American	0

**Age**
From 65 to 74	392
From 75 to 84	301
85 and over	91
Less than 65	77

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2020

Hypertension	70
High Cholesterol	61
Stroke	5
Ischemic Heart Disease	38
Depression	22
Chronic Kidney Disease	43
Asthma	8
Osteoperosis	13
Atrial Fibrilation	11
Heart Failure	22
Chronic Obstructive Pulmonary Disease	19
Diabetes	38
Dementia	9
Cancer	47

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2021 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	618
blood draw	580
chemotherapy	618
doctor visit	1390
hormone therapy	36
hospital care	115
inpatient care	115
lab tests	6127
minimally invasive procedures	854
port flush	92
preventive care	12
thyroid function tests	348

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	356
Female	496

**Ethnicity**
Non-Hispanic White	574
Black	230
Hispanic	0
Asian	18
Other	15
Native American	0

**Age**
From 65 to 74	397
From 75 to 84	297
85 and over	88
Less than 65	70

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2021

Hypertension	72
High Cholesterol	63
Stroke	6
Ischemic Heart Disease	41
Depression	24
Chronic Kidney Disease	44
Asthma	7
Osteoperosis	15
Atrial Fibrilation	14
Heart Failure	23
Chronic Obstructive Pulmonary Disease	19
Diabetes	37
Dementia	9
Cancer	46

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA during 2022 were lab tests, minimally invasive procedures, blood draw and chemotherapy.

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

biological response modifier (BRM) therapy	550
blood draw	570
chemotherapy	550
doctor visit	1289
hormone therapy	56
hospital care	142
inpatient care	142
lab tests	5583
minimally invasive procedures	799
port flush	95
thyroid function tests	314

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	341
Female	549

**Ethnicity**
Non-Hispanic White	620
Black	227
Hispanic	14
Asian	0
Other	16
Native American	0

**Age**
From 65 to 74	403
From 75 to 84	312
85 and over	108
Less than 65	67

Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP in 2022

Hypertension	75
High Cholesterol	75
Stroke	8
Ischemic Heart Disease	29
Depression	23
Chronic Kidney Disease	27
Asthma	12
Osteoperosis	19
Atrial Fibrilation	17
Heart Failure	22
Chronic Obstructive Pulmonary Disease	22
Diabetes	34
Dementia	5
Cancer	51

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. David Z. Chang, MD, PHD, FACP for Medicare patients.

The highest averages for the top procedures that Dr. David Z. Chang, MD, PHD, FACP treated as a medical oncologist in Newport News, VA were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

aspiration	11
biological response modifier (BRM) therapy	536
blood draw	482
bone marrow tests	22
chemotherapy	536
diagnostic procedures	22
doctor visit	1394
hormone therapy	28
hospital care	316
inpatient care	316
lab tests	4604
minimally invasive procedures	709
preventive care	30
thyroid function tests	125
vaccines	32

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP.

**Gender**
Male	338
Female	444

**Ethnicity**
Black / African American	239
Asian / Pacific Islander	12
Non-Hispanic White	507
Native American / Alaskan Native	0
Hispanic	1
Other	4

**Age**
75 to 84	276
85 and over	79
Less than 65	81
65 to 74	345

Average of Total of Conditions of Medicare patients treated by Dr. David Z. Chang, MD, PHD, FACP From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. David Z. Chang, MD, PHD, FACP treated were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension	66
High Cholesterol	52
Stroke	4
Ischemic Heart Disease	34
Depression	18
Chronic Kidney Disease	35
Asthma	10
Osteoporosis	10
Heart Failure	19
Chronic Obstructive Pulmonary Disease	18
Diabetes	33
Atrial Fibrillation	11
Dementia	8
Cancer	42

Education & Training

Dr. David Z. Chang, MD, PHD, FACP graduated from Dartmouth Medical School. He completed residency at Cleveland Clinic. He is certified by the Board Certification: Medical Oncology and has a state license in Virginia.

Medical School: Dartmouth Medical School

Residency: Cleveland Clinic (2001)

Board Certification: Board Certification: Medical Oncology

Licensed In: Virginia

Affiliations & Hospitals

Dr. David Z. Chang, MD, PHD, FACP is associated with these hospitals and organizations:

Bon Secours Mary Immaculate Hospital

Bon Secours

Bon Secours Mary Immaculate Hospital

Virginia Oncology Associates

Sentara Health

Ratings & Reviews

Dr. David Z. Chang, MD, PHD, FACP does not have any reviews yet, be the first to leave a review of Dr. David Z. Chang, MD, PHD, FACP here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. David Z. Chang, MD, PHD, FACP. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
AstraZeneca Pharmaceuticals LP	$25,738 IMFINZI $22,240	TAGRISSO $3,258	LYNPARZA $125	Enhertu $100	FASLODEX $15
Exelixis Inc.	$11,323 Cabometyx $11,323
Genentech USA, Inc.	$7,010 Avastin $7,010
Celgene Corporation	$6,292 Abraxane $6,292
Bayer HealthCare Pharmaceuticals Inc.	$4,394 Stivarga $4,394
Other	$20,899 Lonsurf $4,253	COSELA $3,000	FRUZAQLA $2,438	BRUKINSA $2,052	ONIVYDE $1,735	Other $7,421

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$35,211
Consulting Fee	$24,349
Travel and Lodging	$8,126
Food and Beverage	$4,783
Honoraria	$3,000
Other	$186

Research Payments

Dr. David Z. Chang, MD, PHD, FACP has received 162 research payments totaling $1,817,723.

Biography

Dr. David Chang, who practices in Newport News, VA and Hampton, VA, is a medical specialist in adult hematology, adult oncology, and medical oncology. After attending Dartmouth Medical School, he completed his residency training at Cleveland Clinic. In his practice, Dr. Chang focuses on cancer. His hospital/clinic affiliations include Virginia Oncology Associates, Bon Secours Mary Immaculate Hospital, and Sentara Health. Dr. Chang's practice in is open to new patients as reported by Bon Secours.